Intramuscular oxytocin versus Syntometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth:a randomised double-blinded clinical trial of effectiveness, side effects and quality of life

Autor: S Burnard, N Dailami, H.A. van der Nelson, Tim Draycott, E Marques, Christy Burden, Mary Alvarez, Dimitrios Siassakos, M Mayer, Stephen O'Brien, Cathy Winter, J Knowlden

Publikováno v: van der Nelson, H, O'Brien, S, Burnard, S, Mayer, M, Alvarez, M, Knowlden, J, Winter, C, Dailami, N, Marques, E, Burden, C, Siassakos, D & Draycott, T 2021, ' Intramuscular oxytocin versus Syntometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth : a randomised double-blinded clinical trial of effectiveness, side effects and quality of life ', BJOG: An International Journal of Obstetrics and Gynaecology, vol. 128, no. 7, pp. 1236-1246 . https://doi.org/10.1111/1471-0528.16622

Objective To compare intramuscular oxytocin, Syntometrine® and carbetocin for prevention of postpartum haemorrhage after vaginal birth. Design Randomised double-blinded clinical trial. Setting Six hospitals in England. Population A total of 5929 nor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b6210db9cefad35ee6593ff3d0e2c9e
https://research-information.bris.ac.uk/en/publications/532d2ed1-9782-410c-8a27-2c8c4cbc7437

The EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’) is an effective inhibitor of tamoxifen-resistant breast cancer growth

Autor: I. Hutcheson, H. Jones, Denise Barrow, Robert Ian Nicholson, Maureen Elaine Harper, J. Knowlden, A. E. Wakeling, Julia Margaret Wendy Gee

Publikováno v: European Journal of Cancer. 37:S261

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a259a14c6cb4ec1b6174015a482c7ad
https://doi.org/10.1016/s0959-8049(01)81461-1

The biology of antihormone failure in breast cancer.

Autor: Nicholson RI; Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK. nicholsonri@cardiff.ac.uk, Gee JM, Knowlden J, McClelland R, Madden TA, Barrow D, Hutcheson I

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2003; Vol. 80 Suppl 1, pp. S29-34; discussion S35.

Pure antiestrogens. The most important advance in the endocrine therapy of breast cancer since 1896.

Autor: Nicholson RI; Tenovus Cancer Research Center, University of Wales, College of Medicine, Cardiff, United Kingdom., Gee JM, Bryant S, Francis AB, McClelland RA, Knowlden J, Wakeling AE, Osborne CK

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 1996 Apr 30; Vol. 784, pp. 325-35.

Identification and independent regulation of human mesangial cell metalloproteinases.

Autor: Martin J; Institute of Nephrology, University of Wales College of Medicine, Cardiff Royal Infirmary, United Kingdom., Knowlden J, Davies M, Williams JD

Publikováno v: Kidney international [Kidney Int] 1994 Sep; Vol. 46 (3), pp. 877-85.